| Bioactivity | (E)-[6]-Dehydroparadol, an oxidative metabolite of [6]-Shogaol (HY-14616), is a potent Nrf2 activator. (E)-[6]-Dehydroparadol can inhibit the growth and induce the apoptosis of human cancer cells[1][2]. | ||||||||||||
| Invitro | (E)-[6]-Dehydroparadol (M15) (5-80 µM; 24 h) inhibits the growth of HCT-116 and H-1299 cells, with IC50s of 43.02 and 41.59 µM, respectively[1].(E)-[6]-Dehydroparadol (10-40 µM; 24 h) induces apoptosis in HCT-116 and H-1299 cells[1]. | ||||||||||||
| Name | (E)-[6]-Dehydroparadol | ||||||||||||
| CAS | 878006-06-5 | ||||||||||||
| Formula | C17H24O3 | ||||||||||||
| Molar Mass | 276.37 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
(E)-[6]-Dehydroparadol
CAS: 878006-06-5 F: C17H24O3 W: 276.37
(E)--Dehydroparadol, an oxidative metabolite of -Shogaol (HY-14616), is a potent Nrf2 activator. (E)--Dehydroparadol can
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.